Share Price and Basic Stock Data
Last Updated: January 19, 2026, 10:07 pm
| PEG Ratio | -2.28 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Supreme Petrochem Ltd operates in the petrochemicals sector, primarily focusing on polymers. As of the latest reporting, the company’s stock price stood at ₹544, with a market capitalization of ₹10,227 Cr. The company reported sales of ₹5,287 Cr for the fiscal year ending March 2023, reflecting growth from ₹5,032 Cr in the previous fiscal year. Over the trailing twelve months (TTM), sales increased to ₹5,431 Cr. Quarterly sales figures showed fluctuations, with the highest quarterly sales recorded at ₹1,563 Cr in March 2024. The company’s operational performance demonstrated resilience, maintaining an average operating profit margin (OPM) of approximately 10% in recent quarters, despite a challenging economic landscape. While the company’s revenue growth trajectory appears promising, it is essential to monitor market dynamics that could influence future sales, particularly in the volatile petrochemical sector.
Profitability and Efficiency Metrics
Supreme Petrochem reported a net profit of ₹307 Cr for the fiscal year ending March 2025, down from ₹498 Cr in the previous year, indicating a decline in profitability. The company’s return on equity (ROE) stood at 17.4%, while the return on capital employed (ROCE) was recorded at 22.8%, both of which reflect healthy profitability ratios compared to industry standards. The operating profit for the most recent quarter stood at ₹175 Cr, with an OPM of 11%. However, the net profit margin declined to 6.48% in March 2025, down from 9.42% in the previous year. The interest coverage ratio (ICR) was notably strong at 48.80x, indicating that the company comfortably covers its interest obligations. Such metrics underscore the company’s operational efficiency, although the declining net profit margin raises concerns about cost management in an increasingly competitive environment.
Balance Sheet Strength and Financial Ratios
The balance sheet of Supreme Petrochem indicates a robust financial position, with total assets reported at ₹3,448 Cr for the fiscal year ending March 2025. The company maintained reserves of ₹2,182 Cr, showcasing a solid buffer for future growth and investments. Borrowings stood at ₹140 Cr, representing a conservative leverage ratio, which is favorable compared to typical industry standards. The price-to-book value (P/BV) ratio was recorded at 5.29x, indicating a premium valuation relative to its book value of ₹118.66 per share. The current ratio of 1.91 and quick ratio of 1.24 suggest that the company is well-positioned to meet its short-term liabilities. However, the declining trend in net profits and profitability ratios should prompt management to reassess operational strategies to enhance shareholder value and ensure long-term sustainability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Supreme Petrochem reveals a stable ownership structure, with promoters holding 64.24% of the equity. This substantial promoter stake indicates strong management commitment and alignment with shareholder interests. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) held 3.69% and 3.87%, respectively, as of the latest reporting period, reflecting moderate institutional interest. The public shareholding stood at 28.10%, with a total of 46,388 shareholders. The slight decline in the number of shareholders from earlier periods may suggest a consolidation of investor confidence. However, the relatively low FII and DII participation could indicate caution among institutional investors, potentially reflecting broader market sentiments regarding the petrochemical sector’s volatility and challenges.
Outlook, Risks, and Final Insight
Looking ahead, Supreme Petrochem faces both opportunities and challenges. The company’s strong operational metrics, including a high interest coverage ratio and solid ROCE, provide a foundation for potential growth. However, risks such as fluctuating raw material prices, competition, and macroeconomic uncertainties could impact profitability. Additionally, the decline in net profit and margins raises concerns about operational efficiency and cost control. The company must navigate these challenges to sustain its growth trajectory. While there are opportunities for expansion in polymer markets, particularly with growing demand in various sectors, management’s ability to respond effectively to market dynamics will determine the company’s future performance. Enhancing operational efficiencies and exploring strategic partnerships could be pivotal in mitigating risks and maximizing shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Fluoro Carbons Ltd | 31.8 Cr. | 16.2 | 19.6/10.8 | 265 | 41.8 | 0.00 % | 1.02 % | % | 10.0 |
| Gujarat Petrosynthese Ltd | 32.9 Cr. | 55.1 | 81.5/51.5 | 17.0 | 85.2 | 0.00 % | 4.45 % | 2.93 % | 10.0 |
| AVI Polymers Ltd | 7.27 Cr. | 17.8 | 34.6/9.89 | 2.38 | 19.5 | 0.00 % | 19.4 % | 15.6 % | 10.0 |
| Supreme Petrochem Ltd | 10,010 Cr. | 533 | 982/518 | 32.6 | 118 | 1.88 % | 22.8 % | 17.4 % | 2.00 |
| Signet Industries Ltd | 146 Cr. | 48.7 | 81.8/39.0 | 7.16 | 80.3 | 1.03 % | 13.7 % | 6.88 % | 10.0 |
| Industry Average | 3,152.86 Cr | 148.40 | 49.77 | 83.12 | 0.98% | 14.57% | 13.10% | 7.55 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,235 | 1,180 | 1,387 | 1,225 | 1,278 | 1,188 | 1,563 | 1,573 | 1,506 | 1,405 | 1,539 | 1,387 | 1,100 |
| Expenses | 1,156 | 1,061 | 1,179 | 1,135 | 1,171 | 1,093 | 1,388 | 1,412 | 1,380 | 1,306 | 1,394 | 1,272 | 1,023 |
| Operating Profit | 79 | 119 | 208 | 90 | 106 | 95 | 175 | 161 | 125 | 99 | 145 | 115 | 78 |
| OPM % | 6% | 10% | 15% | 7% | 8% | 8% | 11% | 10% | 8% | 7% | 9% | 8% | 7% |
| Other Income | 12 | 14 | 21 | 18 | 16 | 16 | 19 | 23 | 17 | 17 | 19 | 15 | 9 |
| Interest | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 11 | 11 | 14 | 14 | 14 | 15 | 16 | 16 | 17 | 17 | 17 | 18 | 18 |
| Profit before tax | 78 | 121 | 215 | 94 | 106 | 92 | 177 | 164 | 122 | 96 | 143 | 109 | 65 |
| Tax % | 24% | 26% | 26% | 26% | 26% | 27% | 26% | 26% | 26% | 26% | 25% | 25% | 26% |
| Net Profit | 60 | 90 | 159 | 69 | 78 | 68 | 132 | 122 | 90 | 71 | 107 | 81 | 48 |
| EPS in Rs | 3.18 | 4.78 | 8.47 | 3.68 | 4.15 | 3.60 | 6.99 | 6.49 | 4.80 | 3.79 | 5.68 | 4.30 | 2.56 |
Last Updated: December 28, 2025, 11:34 pm
Below is a detailed analysis of the quarterly data for Supreme Petrochem Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,100.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,387.00 Cr. (Jun 2025) to 1,100.00 Cr., marking a decrease of 287.00 Cr..
- For Expenses, as of Sep 2025, the value is 1,023.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,272.00 Cr. (Jun 2025) to 1,023.00 Cr., marking a decrease of 249.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 78.00 Cr.. The value appears to be declining and may need further review. It has decreased from 115.00 Cr. (Jun 2025) to 78.00 Cr., marking a decrease of 37.00 Cr..
- For OPM %, as of Sep 2025, the value is 7.00%. The value appears to be declining and may need further review. It has decreased from 8.00% (Jun 2025) to 7.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Jun 2025) to 9.00 Cr., marking a decrease of 6.00 Cr..
- For Interest, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
- For Depreciation, as of Sep 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 18.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 65.00 Cr.. The value appears to be declining and may need further review. It has decreased from 109.00 Cr. (Jun 2025) to 65.00 Cr., marking a decrease of 44.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Jun 2025) to 26.00%, marking an increase of 1.00%.
- For Net Profit, as of Sep 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 81.00 Cr. (Jun 2025) to 48.00 Cr., marking a decrease of 33.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.56. The value appears to be declining and may need further review. It has decreased from 4.30 (Jun 2025) to 2.56, marking a decrease of 1.74.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:34 am
| Metric | Jun 2014 | Jun 2015 | Mar 2016n n 9m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,264 | 2,653 | 2,068 | 2,919 | 3,027 | 3,194 | 2,724 | 3,185 | 5,032 | 5,287 | 5,253 | 6,023 | 5,431 |
| Expenses | 3,175 | 2,559 | 1,964 | 2,621 | 2,830 | 3,100 | 2,576 | 2,511 | 4,126 | 4,626 | 4,780 | 5,488 | 4,995 |
| Operating Profit | 90 | 93 | 104 | 297 | 196 | 93 | 148 | 674 | 907 | 661 | 473 | 535 | 436 |
| OPM % | 3% | 4% | 5% | 10% | 6% | 3% | 5% | 21% | 18% | 12% | 9% | 9% | 8% |
| Other Income | 6 | 3 | 3 | 7 | 8 | 10 | 12 | 16 | 30 | 59 | 65 | 73 | 60 |
| Interest | 23 | 17 | 5 | 5 | 5 | 4 | 6 | 7 | 7 | 6 | 10 | 15 | 12 |
| Depreciation | 29 | 24 | 17 | 22 | 21 | 23 | 36 | 39 | 42 | 47 | 59 | 68 | 71 |
| Profit before tax | 44 | 56 | 85 | 278 | 179 | 76 | 118 | 644 | 888 | 667 | 468 | 525 | 413 |
| Tax % | 31% | 37% | 33% | 35% | 35% | 35% | 13% | 26% | 25% | 25% | 26% | 26% | |
| Net Profit | 31 | 36 | 57 | 179 | 116 | 49 | 103 | 477 | 663 | 498 | 346 | 391 | 307 |
| EPS in Rs | 1.58 | 1.85 | 2.96 | 9.30 | 6.02 | 2.55 | 5.32 | 25.40 | 35.28 | 26.49 | 18.43 | 20.77 | 16.33 |
| Dividend Payout % | 47% | 41% | 51% | 24% | 37% | 59% | 52% | 30% | 22% | 42% | 49% | 48% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -35.20% | -57.76% | 110.20% | 363.11% | 38.99% | -24.89% | -30.52% | 13.01% |
| Change in YoY Net Profit Growth (%) | 0.00% | -22.56% | 167.96% | 252.90% | -324.11% | -63.88% | -5.64% | 43.53% |
Supreme Petrochem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 17% |
| 3 Years: | 6% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 29% |
| 3 Years: | -17% |
| TTM: | -12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 49% |
| 3 Years: | 26% |
| 1 Year: | -10% |
| Return on Equity | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 29% |
| 3 Years: | 20% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 1:40 pm
Balance Sheet
Last Updated: December 4, 2025, 2:03 am
| Month | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 94 | 38 | 38 | 38 | 38 | 38 |
| Reserves | 268 | 280 | 318 | 486 | 549 | 546 | 577 | 971 | 1,478 | 1,806 | 1,982 | 2,194 | 2,182 |
| Borrowings | 32 | 0 | 0 | 0 | 0 | 0 | 29 | 41 | 37 | 17 | 114 | 130 | 140 |
| Other Liabilities | 587 | 505 | 523 | 548 | 650 | 578 | 552 | 649 | 725 | 870 | 932 | 1,087 | 922 |
| Total Liabilities | 984 | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 3,448 | 3,282 |
| Fixed Assets | 371 | 345 | 333 | 337 | 333 | 331 | 371 | 359 | 337 | 527 | 769 | 813 | 1,486 |
| CWIP | 4 | 4 | 10 | 13 | 10 | 24 | 8 | 9 | 179 | 108 | 233 | 582 | 41 |
| Investments | 0 | 0 | 0 | 0 | 111 | 251 | 135 | 470 | 484 | 563 | 572 | 435 | 235 |
| Other Assets | 608 | 532 | 595 | 780 | 842 | 615 | 741 | 917 | 1,279 | 1,534 | 1,492 | 1,618 | 1,520 |
| Total Assets | 984 | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 3,448 | 3,282 |
Below is a detailed analysis of the balance sheet data for Supreme Petrochem Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 38.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,182.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,194.00 Cr. (Mar 2025) to 2,182.00 Cr., marking a decrease of 12.00 Cr..
- For Borrowings, as of Sep 2025, the value is 140.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 130.00 Cr. (Mar 2025) to 140.00 Cr., marking an increase of 10.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 922.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,087.00 Cr. (Mar 2025) to 922.00 Cr., marking a decrease of 165.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,282.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,448.00 Cr. (Mar 2025) to 3,282.00 Cr., marking a decrease of 166.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,486.00 Cr.. The value appears strong and on an upward trend. It has increased from 813.00 Cr. (Mar 2025) to 1,486.00 Cr., marking an increase of 673.00 Cr..
- For CWIP, as of Sep 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 582.00 Cr. (Mar 2025) to 41.00 Cr., marking a decrease of 541.00 Cr..
- For Investments, as of Sep 2025, the value is 235.00 Cr.. The value appears to be declining and may need further review. It has decreased from 435.00 Cr. (Mar 2025) to 235.00 Cr., marking a decrease of 200.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,520.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,618.00 Cr. (Mar 2025) to 1,520.00 Cr., marking a decrease of 98.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,282.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,448.00 Cr. (Mar 2025) to 3,282.00 Cr., marking a decrease of 166.00 Cr..
Notably, the Reserves (2,182.00 Cr.) exceed the Borrowings (140.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Jun 2014 | Jun 2015 | Mar 2016n n 9m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 58.00 | 93.00 | 104.00 | 297.00 | 196.00 | 93.00 | 119.00 | 633.00 | 870.00 | 644.00 | 359.00 | 405.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 38 | 33 | 50 | 38 | 36 | 33 | 33 | 44 | 30 | 25 | 27 | 24 |
| Inventory Days | 22 | 29 | 37 | 46 | 44 | 31 | 40 | 51 | 29 | 55 | 39 | 50 |
| Days Payable | 60 | 61 | 83 | 65 | 80 | 60 | 74 | 90 | 50 | 66 | 66 | 66 |
| Cash Conversion Cycle | -0 | 1 | 3 | 19 | -0 | 3 | -0 | 4 | 8 | 14 | 0 | 8 |
| Working Capital Days | 1 | 3 | 8 | 22 | 12 | 5 | 5 | 19 | 8 | 19 | 1 | 4 |
| ROCE % | 16% | 19% | 22% | 57% | 30% | 12% | 18% | 72% | 66% | 37% | 22% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HSBC Small Cap Fund | 3,065,168 | 1.21 | 196.74 | 3,365,768 | 2025-12-15 04:11:05 | -8.93% |
| ICICI Prudential Smallcap Fund | 1,567,491 | 1.19 | 100.61 | 1,279,661 | 2025-12-15 04:11:05 | 22.49% |
| Mahindra Manulife Small Cap Fund | 1,041,116 | 1.58 | 66.82 | 1,019,078 | 2025-12-15 04:11:05 | 2.16% |
| ICICI Prudential Childrens Fund | 403,273 | 1.82 | 25.88 | 341,213 | 2025-12-15 01:45:28 | 18.19% |
| ITI ELSS Tax Saver Fund | 74,485 | 1.08 | 4.78 | N/A | N/A | N/A |
| ICICI Prudential Commodities Fund | 26,302 | 0.05 | 1.69 | N/A | N/A | N/A |
| ICICI Prudential Multicap Fund | 4,559 | 0 | 0.29 | N/A | N/A | N/A |
| ICICI Prudential Manufacturing Fund | 2,470 | 0 | 0.16 | 2,449 | 2025-12-15 04:11:05 | 0.86% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 4.00 | 10.00 |
| Basic EPS (Rs.) | 20.77 | 18.43 | 26.49 | 70.54 | 50.63 |
| Diluted EPS (Rs.) | 20.77 | 18.43 | 26.49 | 70.54 | 50.63 |
| Cash EPS (Rs.) | 24.38 | 21.59 | 28.97 | 75.00 | 54.95 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 118.66 | 107.38 | 98.06 | 161.20 | 113.26 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 118.66 | 107.38 | 98.06 | 161.20 | 113.26 |
| Dividend / Share (Rs.) | 10.00 | 9.00 | 9.00 | 7.20 | 15.00 |
| Revenue From Operations / Share (Rs.) | 320.32 | 279.37 | 281.17 | 535.23 | 338.77 |
| PBDIT / Share (Rs.) | 32.22 | 28.45 | 38.13 | 99.54 | 73.41 |
| PBIT / Share (Rs.) | 28.60 | 25.28 | 35.66 | 95.09 | 69.25 |
| PBT / Share (Rs.) | 27.94 | 24.90 | 35.46 | 94.43 | 68.47 |
| Net Profit / Share (Rs.) | 20.77 | 18.43 | 26.49 | 70.54 | 50.78 |
| PBDIT Margin (%) | 10.05 | 10.18 | 13.56 | 18.59 | 21.66 |
| PBIT Margin (%) | 8.92 | 9.05 | 12.68 | 17.76 | 20.44 |
| PBT Margin (%) | 8.72 | 8.91 | 12.61 | 17.64 | 20.21 |
| Net Profit Margin (%) | 6.48 | 6.59 | 9.42 | 13.18 | 14.99 |
| Return on Networth / Equity (%) | 17.50 | 17.16 | 27.01 | 43.76 | 44.84 |
| Return on Capital Employeed (%) | 22.53 | 21.94 | 35.49 | 56.82 | 57.42 |
| Return On Assets (%) | 11.32 | 11.30 | 18.23 | 29.11 | 27.20 |
| Asset Turnover Ratio (%) | 1.85 | 1.81 | 2.11 | 2.50 | 2.12 |
| Current Ratio (X) | 1.91 | 2.23 | 2.41 | 2.48 | 2.20 |
| Quick Ratio (X) | 1.24 | 1.69 | 1.64 | 2.05 | 1.68 |
| Inventory Turnover Ratio (X) | 10.20 | 5.77 | 6.79 | 8.74 | 5.55 |
| Dividend Payout Ratio (NP) (%) | 45.74 | 48.84 | 33.97 | 23.38 | 7.87 |
| Dividend Payout Ratio (CP) (%) | 38.96 | 41.68 | 31.06 | 22.00 | 7.27 |
| Earning Retention Ratio (%) | 54.26 | 51.16 | 66.03 | 76.62 | 92.13 |
| Cash Earning Retention Ratio (%) | 61.04 | 58.32 | 68.94 | 78.00 | 92.73 |
| Interest Coverage Ratio (X) | 48.80 | 74.07 | 200.52 | 149.99 | 94.93 |
| Interest Coverage Ratio (Post Tax) (X) | 32.46 | 48.98 | 140.30 | 107.29 | 66.68 |
| Enterprise Value (Cr.) | 11337.80 | 11193.68 | 6625.88 | 8246.18 | 3825.67 |
| EV / Net Operating Revenue (X) | 1.88 | 2.13 | 1.25 | 1.64 | 1.20 |
| EV / EBITDA (X) | 18.72 | 20.93 | 9.24 | 8.81 | 5.54 |
| MarketCap / Net Operating Revenue (X) | 1.96 | 2.23 | 1.32 | 1.73 | 1.23 |
| Retention Ratios (%) | 54.25 | 51.15 | 66.02 | 76.61 | 92.12 |
| Price / BV (X) | 5.29 | 5.80 | 3.78 | 5.74 | 3.69 |
| Price / Net Operating Revenue (X) | 1.96 | 2.23 | 1.32 | 1.73 | 1.23 |
| EarningsYield | 0.03 | 0.02 | 0.07 | 0.07 | 0.12 |
After reviewing the key financial ratios for Supreme Petrochem Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 20.77. This value is within the healthy range. It has increased from 18.43 (Mar 24) to 20.77, marking an increase of 2.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is 20.77. This value is within the healthy range. It has increased from 18.43 (Mar 24) to 20.77, marking an increase of 2.34.
- For Cash EPS (Rs.), as of Mar 25, the value is 24.38. This value is within the healthy range. It has increased from 21.59 (Mar 24) to 24.38, marking an increase of 2.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 118.66. It has increased from 107.38 (Mar 24) to 118.66, marking an increase of 11.28.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 118.66. It has increased from 107.38 (Mar 24) to 118.66, marking an increase of 11.28.
- For Dividend / Share (Rs.), as of Mar 25, the value is 10.00. This value exceeds the healthy maximum of 3. It has increased from 9.00 (Mar 24) to 10.00, marking an increase of 1.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 320.32. It has increased from 279.37 (Mar 24) to 320.32, marking an increase of 40.95.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 32.22. This value is within the healthy range. It has increased from 28.45 (Mar 24) to 32.22, marking an increase of 3.77.
- For PBIT / Share (Rs.), as of Mar 25, the value is 28.60. This value is within the healthy range. It has increased from 25.28 (Mar 24) to 28.60, marking an increase of 3.32.
- For PBT / Share (Rs.), as of Mar 25, the value is 27.94. This value is within the healthy range. It has increased from 24.90 (Mar 24) to 27.94, marking an increase of 3.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 20.77. This value is within the healthy range. It has increased from 18.43 (Mar 24) to 20.77, marking an increase of 2.34.
- For PBDIT Margin (%), as of Mar 25, the value is 10.05. This value is within the healthy range. It has decreased from 10.18 (Mar 24) to 10.05, marking a decrease of 0.13.
- For PBIT Margin (%), as of Mar 25, the value is 8.92. This value is below the healthy minimum of 10. It has decreased from 9.05 (Mar 24) to 8.92, marking a decrease of 0.13.
- For PBT Margin (%), as of Mar 25, the value is 8.72. This value is below the healthy minimum of 10. It has decreased from 8.91 (Mar 24) to 8.72, marking a decrease of 0.19.
- For Net Profit Margin (%), as of Mar 25, the value is 6.48. This value is within the healthy range. It has decreased from 6.59 (Mar 24) to 6.48, marking a decrease of 0.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.50. This value is within the healthy range. It has increased from 17.16 (Mar 24) to 17.50, marking an increase of 0.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.53. This value is within the healthy range. It has increased from 21.94 (Mar 24) to 22.53, marking an increase of 0.59.
- For Return On Assets (%), as of Mar 25, the value is 11.32. This value is within the healthy range. It has increased from 11.30 (Mar 24) to 11.32, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.85. It has increased from 1.81 (Mar 24) to 1.85, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 1.91. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.91, marking a decrease of 0.32.
- For Quick Ratio (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has decreased from 1.69 (Mar 24) to 1.24, marking a decrease of 0.45.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.20. This value exceeds the healthy maximum of 8. It has increased from 5.77 (Mar 24) to 10.20, marking an increase of 4.43.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 45.74. This value is within the healthy range. It has decreased from 48.84 (Mar 24) to 45.74, marking a decrease of 3.10.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 38.96. This value is within the healthy range. It has decreased from 41.68 (Mar 24) to 38.96, marking a decrease of 2.72.
- For Earning Retention Ratio (%), as of Mar 25, the value is 54.26. This value is within the healthy range. It has increased from 51.16 (Mar 24) to 54.26, marking an increase of 3.10.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 61.04. This value is within the healthy range. It has increased from 58.32 (Mar 24) to 61.04, marking an increase of 2.72.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 48.80. This value is within the healthy range. It has decreased from 74.07 (Mar 24) to 48.80, marking a decrease of 25.27.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 32.46. This value is within the healthy range. It has decreased from 48.98 (Mar 24) to 32.46, marking a decrease of 16.52.
- For Enterprise Value (Cr.), as of Mar 25, the value is 11,337.80. It has increased from 11,193.68 (Mar 24) to 11,337.80, marking an increase of 144.12.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.88. This value is within the healthy range. It has decreased from 2.13 (Mar 24) to 1.88, marking a decrease of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is 18.72. This value exceeds the healthy maximum of 15. It has decreased from 20.93 (Mar 24) to 18.72, marking a decrease of 2.21.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.96. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.96, marking a decrease of 0.27.
- For Retention Ratios (%), as of Mar 25, the value is 54.25. This value is within the healthy range. It has increased from 51.15 (Mar 24) to 54.25, marking an increase of 3.10.
- For Price / BV (X), as of Mar 25, the value is 5.29. This value exceeds the healthy maximum of 3. It has decreased from 5.80 (Mar 24) to 5.29, marking a decrease of 0.51.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.96. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.96, marking a decrease of 0.27.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Supreme Petrochem Ltd:
- Net Profit Margin: 6.48%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.53% (Industry Average ROCE: 14.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.5% (Industry Average ROE: 13.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 32.46
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.24
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 32.6 (Industry average Stock P/E: 49.77)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.48%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Petrochemicals - Polymers | Solitaire Corporate Park, Building No. 11, Mumbai Maharashtra 400093 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. M P Taparia | Chairperson |
| Mr. Rajan B Raheja | Non Independent Director |
| Mr. B L Taparia | Non Independent Director |
| Mr. S J Taparia | Non Independent Director |
| Mr. Rajeev M Pandia | Independent Director |
| Mr. Akshay R Raheja | Non Independent Director |
| Mr. Anup Kumar Ghosh | Independent Director |
| Mr. Basavaraj N Bankapur | Independent Director |
| Mr. Sanjay R Chougule | Independent Director |
| Ms. Rita A Teaotia | Independent Director |
| Ms. Mona N Desai | Independent Director |
FAQ
What is the intrinsic value of Supreme Petrochem Ltd?
Supreme Petrochem Ltd's intrinsic value (as of 19 January 2026) is ₹467.65 which is 12.26% lower the current market price of ₹533.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹10,010 Cr. market cap, FY2025-2026 high/low of ₹982/518, reserves of ₹2,182 Cr, and liabilities of ₹3,282 Cr.
What is the Market Cap of Supreme Petrochem Ltd?
The Market Cap of Supreme Petrochem Ltd is 10,010 Cr..
What is the current Stock Price of Supreme Petrochem Ltd as on 19 January 2026?
The current stock price of Supreme Petrochem Ltd as on 19 January 2026 is ₹533.
What is the High / Low of Supreme Petrochem Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Supreme Petrochem Ltd stocks is ₹982/518.
What is the Stock P/E of Supreme Petrochem Ltd?
The Stock P/E of Supreme Petrochem Ltd is 32.6.
What is the Book Value of Supreme Petrochem Ltd?
The Book Value of Supreme Petrochem Ltd is 118.
What is the Dividend Yield of Supreme Petrochem Ltd?
The Dividend Yield of Supreme Petrochem Ltd is 1.88 %.
What is the ROCE of Supreme Petrochem Ltd?
The ROCE of Supreme Petrochem Ltd is 22.8 %.
What is the ROE of Supreme Petrochem Ltd?
The ROE of Supreme Petrochem Ltd is 17.4 %.
What is the Face Value of Supreme Petrochem Ltd?
The Face Value of Supreme Petrochem Ltd is 2.00.